Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]
Mombo-Ngoma G +10 more
europepmc +1 more source
Is heme metabolism a promising drug target in Toxoplasma gondii? [PDF]
Dou Z.
europepmc +1 more source
Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer's Disease. [PDF]
Kiss E +5 more
europepmc +1 more source
Treatment Failure and Post-Artesunate Delayed Haemolysis in a Returned Traveller From Uganda With Partially Drug-Resistant Severe Plasmodium falciparum Malaria. [PDF]
Travis J +6 more
europepmc +1 more source
A fatal case report of <i>Plasmodium falciparum</i> malaria complicated by acute subdural hematoma. [PDF]
Xie N, Ye H, Jiang X.
europepmc +1 more source
Nanoparticle based drug delivery systems improve antimalarial efficacy and vaccine performance in African research and clinical settings. [PDF]
Dangana RS +4 more
europepmc +1 more source
Plasmodium falciparum non-synonymous Kelch13 mutations mediating artemisinin resistance in East Africa: A systematic review and meta-analysis: 2014-2024. [PDF]
Kapesa A +6 more
europepmc +1 more source
The Effect of Artemisinin on the Pharmacokinetics of Cyclophosphamide and Its Metabolite in Mice and Its Potential Mechanisms. [PDF]
Wang H, Zhang W, Hu H, Wang S, Xie Y.
europepmc +1 more source
Transferrin-Conjugated Nanostructured Lipid Carriers for Targeting Artemisone to Melanoma Cells. [PDF]
Altuwaijri N, Atef E.
europepmc +1 more source

